KNSA logo

Kiniksa Pharmaceuticals (KNSA) Shareholders equity

annual shareholders equity:

$438.44M-$403.00K(-0.09%)
December 31, 2024

Summary

  • As of today (May 31, 2025), KNSA annual stockholders equity is $438.44 million, with the most recent change of -$403.00 thousand (-0.09%) on December 31, 2024.
  • During the last 3 years, KNSA annual shareholders equity has risen by +$253.40 million (+136.95%).
  • KNSA annual shareholders equity is now -0.09% below its all-time high of $438.84 million, reached on December 31, 2023.

Performance

KNSA Shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKNSAbalance sheet metrics

quarterly shareholders equity:

$457.49M+$19.05M(+4.35%)
March 31, 2025

Summary

  • As of today (May 31, 2025), KNSA quarterly stockholders equity is $457.49 million, with the most recent change of +$19.05 million (+4.35%) on March 31, 2025.
  • Over the past year, KNSA quarterly shareholders equity has increased by +$25.59 million (+5.93%).
  • KNSA quarterly shareholders equity is now at all-time high.

Performance

KNSA quarterly shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKNSAbalance sheet metrics

Shareholders equity Formula

Shareholders Equity = Total Assets − Total Liabilities

KNSA Shareholders equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-0.1%+5.9%
3 y3 years+136.9%+175.2%
5 y5 years+94.5%+122.3%

KNSA Shareholders equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-0.1%+136.9%at high+198.1%
5 y5-year-0.1%+136.9%at high+198.1%
alltimeall time-0.1%+588.7%at high+610.0%

KNSA Shareholders equity History

DateAnnualQuarterly
Mar 2025
-
$457.49M(+4.3%)
Dec 2024
$438.44M(-0.1%)
$438.44M(+0.3%)
Sep 2024
-
$437.01M(+0.4%)
Jun 2024
-
$435.10M(+0.7%)
Mar 2024
-
$431.89M(-1.6%)
Dec 2023
$438.84M(+10.8%)
$438.84M(+8.3%)
Sep 2023
-
$405.13M(-1.6%)
Jun 2023
-
$411.66M(+5.5%)
Mar 2023
-
$390.10M(-1.5%)
Dec 2022
$396.15M(+114.1%)
$396.15M(+3.2%)
Sep 2022
-
$384.01M(+150.2%)
Jun 2022
-
$153.49M(-7.7%)
Mar 2022
-
$166.24M(-10.2%)
Dec 2021
$185.04M
$185.04M(-13.6%)
Sep 2021
-
$214.05M(-9.2%)
DateAnnualQuarterly
Jun 2021
-
$235.78M(-12.9%)
Mar 2021
-
$270.70M(-13.2%)
Dec 2020
$311.94M(+38.4%)
$311.94M(-13.0%)
Sep 2020
-
$358.51M(+43.2%)
Jun 2020
-
$250.42M(+21.7%)
Mar 2020
-
$205.83M(-8.7%)
Dec 2019
$225.42M(-19.3%)
$225.42M(-10.5%)
Sep 2019
-
$251.91M(-8.5%)
Jun 2019
-
$275.20M(-10.2%)
Mar 2019
-
$306.52M(+9.8%)
Dec 2018
$279.27M(-411.3%)
$279.27M(-12.4%)
Sep 2018
-
$318.91M(-6.7%)
Jun 2018
-
$341.80M(+66.3%)
Mar 2018
-
$205.48M(-329.1%)
Dec 2017
-$89.71M(+248.6%)
-$89.71M
Dec 2016
-$25.73M
-

FAQ

  • What is Kiniksa Pharmaceuticals annual stockholders equity?
  • What is the all time high annual shareholders equity for Kiniksa Pharmaceuticals?
  • What is Kiniksa Pharmaceuticals annual shareholders equity year-on-year change?
  • What is Kiniksa Pharmaceuticals quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Kiniksa Pharmaceuticals?
  • What is Kiniksa Pharmaceuticals quarterly shareholders equity year-on-year change?

What is Kiniksa Pharmaceuticals annual stockholders equity?

The current annual shareholders equity of KNSA is $438.44M

What is the all time high annual shareholders equity for Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals all-time high annual stockholders equity is $438.84M

What is Kiniksa Pharmaceuticals annual shareholders equity year-on-year change?

Over the past year, KNSA annual stockholders equity has changed by -$403.00K (-0.09%)

What is Kiniksa Pharmaceuticals quarterly stockholders equity?

The current quarterly shareholders equity of KNSA is $457.49M

What is the all time high quarterly shareholders equity for Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals all-time high quarterly stockholders equity is $457.49M

What is Kiniksa Pharmaceuticals quarterly shareholders equity year-on-year change?

Over the past year, KNSA quarterly stockholders equity has changed by +$25.59M (+5.93%)
On this page